In this review, we present a clinical case report and discussion to outline the importance of
long-term specific Fanconi anemia (FA) monitoring, and we discuss the main aspects of the …

Fanconi anaemia is a challenging disease to manage, and haematopoietic stem-cell
transplantation (HSCT) is the treatment of choice for the haematological complications …

Fanconi anemia (FA) is a rare inherited disorder that mainly affects the bone marrow. This
condition causes decreased production of all types of blood cells. FA is caused by a …

Inherited bone marrow failure syndromes (IBMFSs) are a group of rare genetic disorders
characterized by bone marrow failure with unique phenotypes and predisposition to cancer …

Introduction Inherited bone marrow failure syndromes (IBMFS) feature complex molecular
pathophysiology resulting in ineffective hematopoiesis and increased risk of progression to …

Haematopoietic cell transplantation (HCT) is the only curative treatment for haematological
complications in patients with Fanconi anaemia (FA). Haploidentical (haplo‐) HCT is a …

Fanconi anemia (FA) has long been considered a severe inherited bone marrow failure
(BMF) disorder of early childhood. Thus, management of this multisystem disorder has …

Fanconi anemia (FA) is a rare inherited disorder that mainly affects the bone marrow. This
condition causes decreased production of all types of blood cells. FA is caused by a …

Irreversible severe bone marrow failure (BMF) is a life-threatening condition in pediatric
patients. Most important causes are inherited bone marrow failure syndromes (IBMFSs) and …

Hematopoietic cell transplantation (HCT) remains the sole available curative treatment for
Fanconi anemia (FA), with particularly favorable outcomes reported after matched sibling …